AGP Picks
View all

Medical Industry Today
Provided by AGP

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 15, 2026

Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
May 15, 2026

Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing

Indeterminate GlobeNewswire
Recor Medical Highlights Innovation and Global Action on World Hypertension Day 2026
May 15, 2026

Recor Medical Highlights Innovation and Global Action on World Hypertension Day 2026

Indeterminate GlobeNewswire
Vaso Corporation Announces Financial Results for First Quarter of 2026
May 15, 2026

Vaso Corporation Announces Financial Results for First Quarter of 2026

Indeterminate GlobeNewswire
Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
May 15, 2026

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Indeterminate GlobeNewswire
Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress
May 15, 2026

Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress

Indeterminate GlobeNewswire
Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results
May 15, 2026

Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results

Indeterminate GlobeNewswire
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
May 15, 2026

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

Indeterminate GlobeNewswire
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
May 15, 2026

Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.

Indeterminate GlobeNewswire
Sienna Announces May Dividend
May 15, 2026

Sienna Announces May Dividend

Indeterminate GlobeNewswire
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
May 15, 2026

SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies

Indeterminate GlobeNewswire
CytoDyn to Present at the LD Micro Invitational XVI
May 15, 2026

CytoDyn to Present at the LD Micro Invitational XVI

Indeterminate GlobeNewswire
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
May 15, 2026

Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial
May 15, 2026

Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial

Indeterminate GlobeNewswire
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
May 15, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
May 15, 2026

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds

Indeterminate GlobeNewswire
Research Highlights Diet and Hormone Therapy Advances in Preventing Recurrent UTIs in Women
May 15, 2026

Research Highlights Diet and Hormone Therapy Advances in Preventing Recurrent UTIs in Women

Indeterminate GlobeNewswire
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
May 15, 2026

Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May 15, 2026

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

Indeterminate GlobeNewswire
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

Indeterminate GlobeNewswire
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May 15, 2026

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.